Topics:

Legislation Urged to Revitalize the National Cancer Plan

Legislation Urged to Revitalize the National Cancer Plan

WASHINGTON—Major congressional and White House action is needed to
revitalize the National Cancer Plan and enable "our nation to capitalize
on unprecedented scientific opportunities and surmount barriers" in the
battle against cancer, an independent panel has concluded.

In its report, "Conquering Cancer: A National Battle Plan to Eradicate Cancer in Our Lifetime," the National
Cancer Legislation Advisory Committee (NCLAC) made 34 recommendations aimed at
basic and translational research, the delivery of cancer care, and access to
cancer care.

"Congress and the President can act immediately on some of the ideas, while others may be long term," the
panel said. "Taken together, however, these recommendations provide a road
map to eradicating cancer as a major health problem in our lifetime—a goal
that is finally within reach."

NCLAC was formed in 1999 at the request of Sen. Dianne Feinstein (D-Calif).
"I now believe that in my lifetime we can find a cure for cancer,"
she said, and promised to introduce legislation later this year that would
"form our nation’s battle plan to win this war."

Former National Cancer Institute director Vincent T. DeVita, Jr., MD,
director of the Yale Comprehensive Cancer Center, and John R. Seffrin, PhD,
chief executive officer of the American Cancer Society, co-chaired NCLAC.

What became known as the "War on Cancer" began with the enactment
of the National Cancer Act, which then-President Richard M. Nixon signed into
law in December 1971. Researchers and clinicians have made remarkable progress
in the 30 years since, the report noted.

"For the first time in our nation’s history, the number of new cancer
cases and deaths for every 100,000 people has declined over the past decade.
For many, a cancer diagnosis is no longer a death sentence," the panel
said.

Pages

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.